Heterocyclic macrolide pharmaceutical agent, a method of producing the same and use of the same
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 18, 2009
Grant Date -
Oct 19, 2006
app pub date -
Jul 31, 2003
filing date -
Jul 31, 2002
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A compound represented by the following general formula (I):alkoxy, etc.; a pharmaceutically acceptable salt thereof or hydrates of the same. The compound (1) inhibits angiogenesis and inhibits the production of VEGF particularly under hypoxic conditions, which makes it useful as a remedy for solid cancer.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully